沸石咪唑盐骨架
咪唑酯
化学
微流控
纳米技术
药物输送
聚合物
右旋糖酐
涂层
材料科学
阿霉素
体内
生物化学
金属有机骨架
有机化学
化疗
吸附
医学
外科
生物技术
生物
作者
Jie Shen,Ming Ma,Muhammad Shafiq,Huizhu Yu,Zhengyi Lan,Hangrong Chen
标识
DOI:10.1002/anie.202113703
摘要
Abstract The impermeable barriers of solid tumors restrict the co‐delivery of protein‐based drugs and chemotherapeutics for cancer treatment. Therefore, we developed a ZIF‐DOX/RA@DG nanosystem that encapsulates ribonuclease A (RA) and doxorubicin (DOX) in a zeolitic imidazolate framework (ZIF‐8) core, with a dextran‐based coating (DG). The nanosystem exhibits dual‐responsiveness due to γ‐glutamyl transpeptidase‐activatable cationization and acidic microenvironment‐triggered degradation. The DG‐coating process was achieved using a microfluidic approach, which stabilized the polymer responsiveness, ZIF‐8‐based structure, and bioactivity of the encapsulated therapeutics. In vivo results confirmed that the nanosystem could co‐deliver RA and DOX to deep impermeable lesions with a synergistic anticancer therapeutic effects. Such a multi‐drug delivery system based on an intelligent‐responsive design and a microfluidics‐assisted synthesis strategy shows great clinical prospects.
科研通智能强力驱动
Strongly Powered by AbleSci AI